Why the study?
Cancer therapy advancements have improved survival rates but also introduced significant cardiotoxic risks, posing substantial challenges in clinical management.
Design
Systematic review
Authors
Loading...
May guide risk stratification and monitoring in cancer patients on cardiotoxic therapy; supports refined surveillance protocols and targeted research.
Regular cardiac monitoring using advanced imaging and biomarkers, along with multidisciplinary cardiology involvement, is essential for early detection and management of cardiotoxicity in cancer patients.
Hauwanga et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: